MTA Ancillary Agreement: Pittsburgh 2nd Generation Tet Promoter
Please consult the UBMTA for definitions of ORIGINAL MATERIAL and
RECIPIENT regarding this transfer of the ORIGINAL MATERIAL.
By agreeing to this ancillary agreement, the RECIPIENT acknowledges that the Provider asserts the following:
The ORIGINAL MATERIAL may contain second generation tetracycline
regulatable promoter, which is covered by certain issued and pending
patents owned by the University of Pittsburgh.
RECIPIENT understands that the ORIGINAL MATERIAL is experimental in nature
and may have hazardous properties. University of Pittsburgh MAKES NO
REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER
EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE
OF THE ORIGINAL MATERIAL WILL NOT INFRINGE ANY PATENT, COPYRIGHT,
TRADEMARK, OR OTHER PROPRIETARY RIGHTS.
In the event of any conflict between this Ancillary Agreement and the
UBMTA, this Ancillary Agreement shall take precedence.